- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Sonus and HP finish contrast trial
Developmental work continues on EchoGen, an ultrasound contrast agent from Sonus Pharmaceuticals. In conjunction with ultrasound scanner vendor Hewlett-Packard, Sonus has completed an image optimization trial that has determined the scanner control
Developmental work continues on EchoGen, an ultrasound contrast agent from Sonus Pharmaceuticals. In conjunction with ultrasound scanner vendor Hewlett-Packard, Sonus has completed an image optimization trial that has determined the scanner control parameters required to provide the highest level of cardiac image enhancement using its EchoGen ultrasound contrast agent.
The trial, which was conducted at the VA Medical Center in Dallas, consisted of 18 patients who were given EchoGen and then scanned using an HP Sonos 2500 LE echocardiography scanner. Sonos 2500 LE was designed for use in harmonic imaging studies with ultrasound contrast (SCAN 7/3/96).
In addition to determining optimal system settings, researchers found that on average, EchoGen demonstrated a persistence of at least five minutes, according to Sonus, which is headquartered in Bothell, WA.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
